As of 2024-12-14, the Relative Valuation of Gossamer Bio Inc (GOSS) is (7.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.91 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -905.3%.
The range of the Relative Valuation is (4.55) - (7.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (4.55) - (7.72) | (7.33) |
| Upside | -600.5% - -948.4% | -905.3% |
| Date | P/E |
| 2024-12-05 | -1.70 |
| 2024-12-04 | -1.74 |
| 2024-12-03 | -1.73 |
| 2024-12-02 | -1.81 |
| 2024-11-29 | -1.73 |
| 2024-11-27 | -1.74 |
| 2024-11-26 | -1.73 |
| 2024-11-25 | -1.73 |
| 2024-11-22 | -1.72 |
| 2024-11-21 | -1.65 |
| 2024-11-20 | -1.72 |
| 2024-11-19 | -1.77 |
| 2024-11-18 | -1.78 |
| 2024-11-15 | -1.83 |
| 2024-11-14 | -1.91 |
| 2024-11-13 | -2.02 |
| 2024-11-12 | -2.10 |
| 2024-11-11 | -2.13 |
| 2024-11-08 | -2.18 |
| 2024-11-07 | -2.20 |
| 2024-11-06 | -2.20 |
| 2024-11-05 | -2.17 |
| 2024-11-04 | -2.20 |
| 2024-11-01 | -2.16 |
| 2024-10-31 | -2.17 |
| 2024-10-30 | -2.22 |
| 2024-10-29 | -2.26 |
| 2024-10-28 | -2.27 |
| 2024-10-25 | -2.33 |
| 2024-10-24 | -2.23 |
| 2024-10-23 | -2.20 |
| 2024-10-22 | -2.20 |
| 2024-10-21 | -2.28 |
| 2024-10-18 | -2.38 |
| 2024-10-17 | -2.38 |
| 2024-10-16 | -2.40 |
| 2024-10-15 | -2.40 |
| 2024-10-14 | -2.33 |
| 2024-10-11 | -2.39 |
| 2024-10-10 | -2.44 |
| 2024-10-09 | -2.50 |
| 2024-10-08 | -2.53 |
| 2024-10-07 | -2.60 |
| 2024-10-04 | -2.65 |
| 2024-10-03 | -2.50 |
| 2024-10-02 | -2.60 |
| 2024-10-01 | -2.60 |
| 2024-09-30 | -2.44 |
| 2024-09-27 | -2.38 |
| 2024-09-26 | -2.36 |